MedTrace Logo

Using Mother's Raw Milk Could Improve Breastfeeding in Hospitalized Neonates

NCT02819193 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 665

Last updated 2016-06-30

No results posted yet for this study

Summary

Despite the importance of breast milk for sick or preterm neonates, there is currently no consensus regarding the use of raw mother's own milk (MOM) in neonatal units. The aims of this study are to: (a) describe factors associated with the use of raw MOM; (b) investigate the association between early use of raw MOM and breastfeeding continuation at discharge and up to 6 months later.

Conditions

  • Breastfeeding

Interventions

OTHER

raw mother's own milk

Infants receive mother's own milk before day 7.

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Principal Investigators

  • Céline Fischer Fumeaux, MD · Service de Réanimation Néonatale et Néonatologie, Hôpital Femme Mère Enfant, Bron, France

Eligibility

Max Age
42 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2013-06-30
Completion
2013-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02819193 on ClinicalTrials.gov